Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle

M J Spencer1, E Montecino-Rodriguez, K Dorshkind

  • 1Department of Pediatrics, University of California at Los Angeles, California 90095-1606, USA.

Insights

T cells in Duchenne muscular dystrophy (DMD) models are activated within muscles, contributing significantly to disease pathology. Depleting T cells reduces muscle damage, suggesting immune-based therapies could benefit DMD patients.

Area of Science:

  • Immunology
  • Genetics
  • Neurology

Background:

  • Duchenne muscular dystrophy (DMD) and mdx mouse models stem from dystrophin gene mutations.
  • While gene mutations are primary, other factors may exacerbate DMD pathology.

Purpose of the Study:

  • To investigate T cell activation in mdx mouse muscles.
  • To determine if activated T cells contribute to the pathological process in mdx mice.

Main Methods:

  • Flow cytometry to analyze T cell activation markers (CD44high).
  • In vivo antibody-mediated depletion of CD4+ and CD8+ T cells.
  • Adoptive transfer of mdx immune cells with muscle extracts into healthy recipients.

Main Results:

  • Mdx mice showed higher frequencies of activated T cells in blood and muscle, but not lymph nodes, indicating muscle-specific activation.
  • Depletion of CD4+ T cells reduced muscle pathology by 61%; CD8+ T cell depletion reduced it by 75%.
  • Adoptive transfer induced muscle pathology in recipients, confirming immune cell involvement.

Conclusions:

  • T cells play a significant role in promoting pathology in the mdx mouse model of DMD.
  • These findings suggest that immune-based therapeutic strategies may offer benefits for Duchenne muscular dystrophy patients.

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...